Rep. Ro Khanna sold Teleflex (TFX)
Rep. Ro Khanna (D-CA-17) · $1K–$15K · traded Oct 2, 2023
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Oct 2, 2023
- Disclosed
- Nov 8, 2023
- Days to disclose
- 37
- Asset type
- Stock
- As filed
- Teleflex Inc
- Industry
- Medical - Instruments & Supplies · Healthcare
Other trades in this filing
All of Khanna's trades →- Nov 8, 2023$15K–$50K
$15K–$50K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
Bought Thermo Fisher Scientific TMO
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$15K–$50K
Bought Prudential Financial PRU
$15K–$50K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
Sold Old Dominion Freight Line ODFL
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
Bought The Interpublic Group of Companies IPG
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
Bought Genuine Parts Company GPC
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
Bought Fidelity National Information Services FIS
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$50K–$100K
$50K–$100K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
Recent Congress trades in TFX
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Jul 16, 2025 · disclosed Aug 13, 2025 · Spouse
- Mar 27, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Feb 25, 2025 · disclosed Mar 27, 2025
- Aug 13, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
$15K–$50K · Traded Jul 12, 2023 · disclosed Aug 13, 2023
- May 19, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
$15K–$50K · Traded Apr 10, 2023 · disclosed May 19, 2023
- Dec 1, 2014$15K–$50K
Sen. Susan M. Collins (R-ME)
$15K–$50K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
Company context for TFX
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
TFX: third_quarter 2026 lobbying report
Issues related to medical device tariffs. Issues related to physician reimbursement, prior authorization, breakthrough medical devices, and obesity treatments.
Public: Oct 19, 2026, 2:14 PM EDTOriginal source ↗TFX: third_quarter 2026 lobbying report
Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members. Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members.
Public: Oct 8, 2026, 3:05 PM EDTOriginal source ↗TFX: second_quarter 2026 lobbying report
Issues related to physician reimbursement, prior authorization, breakthrough medical devices, and obesity treatments. Issues related to medical device tariffs.
Public: Jul 20, 2026, 4:43 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.